• Latest Posts

UPDATE: More Promising Results from Mologen’s New HIV Therapy

Dual HIV Therapy: GSK and Gilead Battle over Whose Drug is the Best

Fresh Cash for a Device that Can Treat Diabetes and Prevent HIV

The 10 Biggest Clinical Success Stories of 2016 in European Biotech

These are our 10 Most Read Biotech Articles of 2016

ADVERTISEMENT

With a new €120M Infusion, Pocket NGS CEO talks Success and Strategy

Video: Chatting with Immunocore about the Potential of Immuno-oncology

UPDATE: The HIV Frontier starts Phase III Vaccine trials in South Africa

It’s World AIDS Day, is Biotech close to an HIV Cure?

One Antibody to Neutralize 98% of All HIV Strains: Closer to a Cure?

USB key Diagnostic could help manage HIV Treatment Anywhere

ADVERTISEMENT